Gary Bakst

414 total citations
18 papers, 338 citations indexed

About

Gary Bakst is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Geriatrics and Gerontology. According to data from OpenAlex, Gary Bakst has authored 18 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 3 papers in Geriatrics and Gerontology. Recurrent topics in Gary Bakst's work include Diabetes Management and Research (11 papers), Diabetes Treatment and Management (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Gary Bakst is often cited by papers focused on Diabetes Management and Research (11 papers), Diabetes Treatment and Management (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Gary Bakst collaborates with scholars based in United States. Gary Bakst's co-authors include Michael P. Kane, Robert A. Hamilton, Robert S. Busch, Jill M. Abelseth, Dean A. Van Vugt, INGE DYRENFURTH, Michel Ferin, Robert Busch, James Figge and Óscar Solís and has published in prestigious journals such as Endocrinology, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and American Journal of Health-System Pharmacy.

In The Last Decade

Gary Bakst

16 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Bakst United States 10 188 80 67 43 32 18 338
Alan J. Winters United States 6 145 0.8× 41 0.5× 78 1.2× 52 1.2× 37 1.2× 9 394
P.A. Melrose United States 10 49 0.3× 87 1.1× 31 0.5× 55 1.3× 14 0.4× 14 316
Prashant Nadkarni United States 6 115 0.6× 87 1.1× 129 1.9× 130 3.0× 25 0.8× 9 372
David Y. Cheng United States 13 82 0.4× 60 0.8× 162 2.4× 14 0.3× 129 4.0× 18 379
Troy L. ZumBrunnen United States 12 87 0.5× 24 0.3× 68 1.0× 29 0.7× 14 0.4× 17 257
Takashi Kano Japan 14 32 0.2× 41 0.5× 89 1.3× 20 0.5× 68 2.1× 35 336
Guoqing Chen China 7 278 1.5× 27 0.3× 72 1.1× 53 1.2× 7 0.2× 12 331
Paul F. Gilliland United States 10 173 0.9× 42 0.5× 29 0.4× 8 0.2× 13 0.4× 14 320
Makoto Ujihara Japan 11 155 0.8× 87 1.1× 109 1.6× 52 1.2× 6 0.2× 26 325
U. Ritzel Germany 7 158 0.8× 84 1.1× 44 0.7× 7 0.2× 30 0.9× 12 390

Countries citing papers authored by Gary Bakst

Since Specialization
Citations

This map shows the geographic impact of Gary Bakst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Bakst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Bakst more than expected).

Fields of papers citing papers by Gary Bakst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Bakst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Bakst. The network helps show where Gary Bakst may publish in the future.

Co-authorship network of co-authors of Gary Bakst

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Bakst. A scholar is included among the top collaborators of Gary Bakst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Bakst. Gary Bakst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kane, Michael P., et al.. (2019). A pharmacist-run anabolic osteoporosis clinic: An abaloparatide descriptive report. Journal of the American Pharmacists Association. 59(4). 593–597. 3 indexed citations
2.
Kane, Michael P., et al.. (2011). Pharmacist-run zoledronic acid clinic. American Journal of Health-System Pharmacy. 68(15). 1399–1403.
3.
Kane, Michael P., et al.. (2009). Accuracy and Precision of Four Value-Added Blood Glucose Meters: the Abbott Optium, the DDI Prodigy, the HDI True Track, and the HypoGuard Assure Pro. Diabetes Technology & Therapeutics. 11(9). 587–592. 8 indexed citations
4.
Kane, Michael P., et al.. (2008). Safety and Efficacy of Exenatide in Combination with Insulin in Patients with Type 2 Diabetes Mellitus. Endocrine Practice. 14(3). 285–292. 65 indexed citations
5.
Kane, Michael P., et al.. (2008). A Glucose Meter Accuracy and Precision Comparison: The FreeStyle Flash Versus the Accu-Chek Advantage, Accu-Chek Compact Plus, Ascensia Contour, and the BD Logic. Diabetes Technology & Therapeutics. 10(2). 102–110. 40 indexed citations
6.
Kane, Michael P., et al.. (2008). Safety and Efficacy of Exenatide in Combination with Insulin in Patients with Type 2 Diabetes Mellitus. Endocrine Practice. 14(3). 285–292. 19 indexed citations
7.
8.
Kane, Michael P., et al.. (2006). Precision and accuracy of two blood glucose meters: FreeStyle Flash versus One Touch Ultra. American Journal of Health-System Pharmacy. 63(15). 1411–1416. 19 indexed citations
9.
Stroup, Jeffrey S., Michael P. Kane, Robert S. Busch, Gary Bakst, & Robert A. Hamilton. (2004). The Utility of Insulin Glargine in the Treatment of Diabetes Mellitus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(6). 736–742. 4 indexed citations
10.
Kane, Michael P., Robert S. Busch, Gary Bakst, & Robert A. Hamilton. (2004). Substitution of Pioglitazone for Troglitazone in Patients with Type 2 Diabetes. Endocrine Practice. 10(1). 18–23. 3 indexed citations
11.
Kane, Michael P., et al.. (2004). Orlistat in Obese Patients with Type 2 Diabetes: A Retrospective Assessment of Weight Loss and Metabolic Effects. Hospital Pharmacy. 39(1). 37–42. 3 indexed citations
12.
Stroup, Jeffrey S., Michael P. Kane, Robert S. Busch, Gary Bakst, & Robert A. Hamilton. (2003). The Diabetes Home Visitation Program. American Journal of Pharmaceutical Education. 67(3). 91–91. 1 indexed citations
13.
Kane, Michael P., et al.. (2003). Accuracy of home blood glucose monitors using forearm blood samples: FreeStyle versus One Touch Ultra. American Journal of Health-System Pharmacy. 60(11). 1130–1135. 17 indexed citations
14.
Stroup, Jeffrey S., et al.. (2003). INSTRUCTIONAL DESIGN AND ASSESSMENT The Diabetes Home Visitation Program. 1 indexed citations
15.
Stroup, Jeffrey S., Michael P. Kane, Robert S. Busch, Gary Bakst, & Robert A. Hamilton. (2003). The Diabetes Home Visitation Program. American Journal of Pharmaceutical Education. 67(3). 91–91. 14 indexed citations
16.
Kane, Michael P., et al.. (2001). Cholesterol and Glycemic Effects of Niaspan in Patients with Type 2 Diabetes. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(12). 1473–1478. 13 indexed citations
17.
Figge, James, et al.. (1991). Image analysis quantitation of immunoreactive retinoblastoma protein in human thyroid neoplasms with a streptavidin-biotin-peroxidase staining technique.. PubMed. 139(6). 1213–9. 24 indexed citations
18.
Vugt, Dean A. Van, Gary Bakst, INGE DYRENFURTH, & Michel Ferin. (1983). Naloxone Stimulation of Luteinizing Hormone Secretion in the Female Monkey: Influence of Endocrine and Experimental Conditions*. Endocrinology. 113(5). 1858–1864. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan J. Winters Breakdown of academic impact, for papers by P.A. Melrose Breakdown of academic impact, for papers by Prashant Nadkarni Breakdown of academic impact, for papers by David Y. Cheng Breakdown of academic impact, for papers by Troy L. ZumBrunnen Breakdown of academic impact, for papers by Takashi Kano Breakdown of academic impact, for papers by Guoqing Chen Breakdown of academic impact, for papers by Paul F. Gilliland Breakdown of academic impact, for papers by Makoto Ujihara Breakdown of academic impact, for papers by U. Ritzel
Rankless by CCL
2026